RecruitingPhase 3NCT02429700
TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors
Studying Malignant sex cord stromal tumor of ovary
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Beihua Kong
- Principal Investigator
- Beihua Kong, MD. PhD.Qilu Hospital of Shandong University
- Intervention
- Paclitaxel(drug)
- Enrollment
- 132 target
- Eligibility
- 14-65 years · FEMALE
- Timeline
- 2015 – 2030
Study locations (1)
- Qilu Hospital of Shandong University, Jinan, Shandong, China
Collaborators
Huazhong University of Science and Technology · Zhejiang University · Sun Yat-sen University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02429700 on ClinicalTrials.govOther trials for Malignant sex cord stromal tumor of ovary
Additional recruiting or active studies for the same condition.
See all trials for Malignant sex cord stromal tumor of ovary →